Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Schellong

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Internal and Emergency Medicine|October 9, 2021
Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolismDiego Martínez-Urbistondo, Rocío G de la Garza, Paula Villares-Fernández, et al.
Journal of Thrombosis and Thrombolysis|November 6, 2023
Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registryPaolo Prandoni, Sylvia Haas, Meg E Fluharty, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Anticoagulant Management After Emergency Surgery or Major Bleeding in Anticoagulated Patients-Results of the Prospective RADOA RegistryJana Last, Ingvild Birschmann, Simone Lindau, et al.
Thrombosis and Haemostasis|March 25, 2016
Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE TrialStefano Barco, Mareike Lankeit, Harald Binder, et al.
European Heart Journal|January 29, 2020
COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventionsSabine Steiner, Andrej Schmidt, Thomas Zeller, et al.
Journal of Clinical Medicine|January 11, 2024
Clinical Course and Management of Patients with Emergency Surgery Treated with Direct Oral Anticoagulants or Vitamin K Antagonists-Results of the German Prospective RADOA-RegistryJana Last, Eva Herrmann, Ingvild Birschmann, et al.
Journal of the American College of Cardiology|November 25, 2017
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced ThrombocytopeniaMarc Schindewolf, Julia Steindl, Jan Beyer-Westendorf, et al.
Thrombosis Research|April 8, 2014
Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry studyMarc Schindewolf, Julia Steindl, Jan Beyer-Westendorf, et al.
Thrombosis and Haemostasis|September 23, 2016
Global Anticoagulant Registry in the Field - Venous Thromboembolism (GARFIELD-VTE). Rationale and designJeffrey I Weitz, Sylvia Haas, Walter Ageno, et al.
Deutsches Arzteblatt International|July 2, 2020
Severe Hemorrhage Associated With Oral AnticoagulantsEdelgard Lindhoff-Last, Eva Herrmann, Simone Lindau, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Internal and Emergency Medicine|October 9, 2021
Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolismDiego Martínez-Urbistondo, Rocío G de la Garza, Paula Villares-Fernández, et al.
Journal of Thrombosis and Thrombolysis|November 6, 2023
Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registryPaolo Prandoni, Sylvia Haas, Meg E Fluharty, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Anticoagulant Management After Emergency Surgery or Major Bleeding in Anticoagulated Patients-Results of the Prospective RADOA RegistryJana Last, Ingvild Birschmann, Simone Lindau, et al.
Thrombosis and Haemostasis|March 25, 2016
Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE TrialStefano Barco, Mareike Lankeit, Harald Binder, et al.
European Heart Journal|January 29, 2020
COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventionsSabine Steiner, Andrej Schmidt, Thomas Zeller, et al.
Journal of Clinical Medicine|January 11, 2024
Clinical Course and Management of Patients with Emergency Surgery Treated with Direct Oral Anticoagulants or Vitamin K Antagonists-Results of the German Prospective RADOA-RegistryJana Last, Eva Herrmann, Ingvild Birschmann, et al.
Journal of the American College of Cardiology|November 25, 2017
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced ThrombocytopeniaMarc Schindewolf, Julia Steindl, Jan Beyer-Westendorf, et al.
Thrombosis Research|April 8, 2014
Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry studyMarc Schindewolf, Julia Steindl, Jan Beyer-Westendorf, et al.
Thrombosis and Haemostasis|September 23, 2016
Global Anticoagulant Registry in the Field - Venous Thromboembolism (GARFIELD-VTE). Rationale and designJeffrey I Weitz, Sylvia Haas, Walter Ageno, et al.
Deutsches Arzteblatt International|July 2, 2020
Severe Hemorrhage Associated With Oral AnticoagulantsEdelgard Lindhoff-Last, Eva Herrmann, Simone Lindau, et al.
Pageof 12